BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 30210115)

  • 1. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
    Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
    Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
    Maruoka D; Arai M; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Nakagawa T; Katsuno T; Yokosuka O
    Dig Endosc; 2017 Jan; 29(1):57-64. PubMed ID: 27492962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
    Tsuchiya I; Kato Y; Tanida E; Masui Y; Kato S; Nakajima A; Izumi M
    Dig Endosc; 2017 Jul; 29(5):576-583. PubMed ID: 28267236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.
    Komori H; Ueyama H; Nagahara A; Akazawa Y; Takeda T; Matsumoto K; Matsumoto K; Asaoka D; Hojo M; Yao T; Watanabe S
    J Int Med Res; 2019 Apr; 47(4):1441-1452. PubMed ID: 30816056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers.
    Kagawa T; Iwamuro M; Ishikawa S; Ishida M; Kuraoka S; Sasaki K; Sakakihara I; Izumikawa K; Yamamoto K; Takahashi S; Tanaka S; Matsuura M; Hasui T; Wato M; Inaba T
    Aliment Pharmacol Ther; 2016 Sep; 44(6):583-91. PubMed ID: 27464849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
    Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
    Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.
    Kobayashi M; Takeuchi M; Hashimoto S; Mizuno K; Sato Y; Narisawa R; Aoyagi Y
    Dig Dis Sci; 2012 Jan; 57(1):119-26. PubMed ID: 21842241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
    Nakamura K; Ihara E; Akiho H; Akahoshi K; Harada N; Ochiai T; Nakamura N; Ogino H; Iwasa T; Aso A; Iboshi Y; Takayanagi R
    Gut Liver; 2016 Nov; 10(6):917-924. PubMed ID: 27282261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers.
    Hirai A; Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Tominaga K; Tokioka S; Higuchi K
    Dig Dis Sci; 2018 Apr; 63(4):974-981. PubMed ID: 29464587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis.
    Kim EH; Park SW; Nam E; Lee JG; Park CH
    Surg Endosc; 2019 Apr; 33(4):1271-1283. PubMed ID: 30167955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
    Ko J; Kim SJ; Kang DH; Choi CW; Kim HW; Park SB
    Medicine (Baltimore); 2019 May; 98(20):e15701. PubMed ID: 31096515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers.
    Yamasaki A; Yoshio T; Muramatsu Y; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Sasaki Y; Fujisaki J
    Digestion; 2018; 97(2):170-176. PubMed ID: 29310111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.
    Xiong J; Lai S; Zhang P; Li Q; Wei Y; Yang Y; Wang T; Liu L; Ma X; Chen D
    Medicine (Baltimore); 2014 Sep; 93(12):e64. PubMed ID: 25211045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis.
    Liu C; Feng BC; Zhang Y; Li LX; Zuo XL; Li YQ
    J Dig Dis; 2019 Oct; 20(10):503-511. PubMed ID: 31414725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.
    Jaruvongvanich V; Poonsombudlert K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1416-1421. PubMed ID: 29985791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis.
    Horikawa Y; Mizutamari H; Mimori N; Kato Y; Fushimi S; Sato S; Okubo S
    Scand J Gastroenterol; 2018 Feb; 53(2):243-251. PubMed ID: 29214885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis.
    Liu J; Xiong Z; Geng X; Cui M
    Biomed Res Int; 2020; 2020():7196782. PubMed ID: 33062694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study.
    Kato T; Araki H; Onogi F; Ibuka T; Sugiyama A; Tomita E; Nagaki M; Moriwaki H
    J Gastroenterol; 2010 Mar; 45(3):285-90. PubMed ID: 19957195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers.
    Jung DH; Park JC; Lee YC; Lee SK; Shin SK; Chung H; Park JJ; Kim JH; Youn YH; Park H
    J Clin Gastroenterol; 2021 Mar; 55(3):233-238. PubMed ID: 32341237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: a meta-analysis.
    Wang J; Guo X; Ye C; Yu S; Zhang J; Song J; Cao Z; Wang J; Liu M; Dong W
    Intern Med; 2014; 53(12):1243-8. PubMed ID: 24930641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.